1. MAINTENANCE RITUXIMAB IMPROVES SURVIVAL IN NEWLY DIAGNOSED MANTLE CELL LYMPHOMA PATIENTS: ANALYSIS OF THE CZECH LYMPHOMA STUDY GROUP. (June 2017) Authors: Obr, A.; Klener, P.; Belada, D.; Pytlik, R.; Simkovic, M.; Salek, D.; Mocikova, H.; Prochazka, V.; Janikova, A.; Markova, J.; Campr, V.; Kodet, R.; Trneny, M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 205 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PRIMARY ANALYSIS RESULTS OF THE SINGLE‐ARM PHASE II STUDY OF MOR208 PLUS LENALIDOMIDE IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (L‐MIND). (12th June 2019) Authors: Salles, G.; Duell, J.; González Barca, E.; Jurczak, W.; Liberati, A.M.; Nagy, Z.; Obr, A.; Gaidano, G.; Andre, M.; Kalakonda, N.; Dreyling, M.; Zinzani, P.L.; Dirnberger‐Hertweck, M.; Weirather, J.; Ambarkhane, S.; Maddocks, K. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 173 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. R‐CHOP/R‐HDAC AND RITUXIMAB MAINTENANCE RESULTS IN HIGH COMPLETE REMISSION RATE, MINIMAL RESIDUAL DISEASE NEGATIVITY, AND EXCELLENT SURVIVAL IN ELDERLY MCL PATIENTS. (June 2017) Authors: Klener, P.; Fronkova, E.; Belada, D.; Forsterova, K.; Pytlik, R.; Kalinova, M.; Simkovic, M.; Salek, D.; Mocikova, H.; Prochazka, V.; Blahovcová, P.; Janikova, A.; Markova, J.; Obr, A.; Berkova, A.; Vaskova, M.; Mejstrikova, E.; Campr, V.; Kubinyi, J.; Jaksa, R. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 204 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗